CANDEL THERAPEUTICS ANNOUNCES NEW DATA SHOWING SUSTAINED IMMUNE REMODELING MORE THAN TWO YEARS AFTER AGLATIMAGENE BESADENOVEC TREATMENT IN LOCALIZED PROSTATE CANCER AT ASTRO 2026

Reuters · 3d ago

Please log in to view news